Evidence map›Paper›PMID 31139877›Full record

Observational studyPsychopharmacology2019

Methadone serum concentrations and influencing factors: A naturalistic observational study.

Fatemeh Chalabianloo, Andreas A Westin, Eirik Skogvoll, Jørgen G Bramness, Olav Spigset

Abstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in Psychopharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Fatemeh ChalabianlooDepartment of Addiction Medicine, Haukeland University Hospital, Bergen, Norway. fatemeh.chalabianloo@helse-bergen.no.ORCID http://orcid.org/0000-0003-1242-1972
Andreas A WestinDepartment of Clinical Pharmacology, St. Olav University Hospital, Trondheim, Norway.
Eirik SkogvollClinic for Anaesthesiology and Intensive Care, St. Olav University Hospital, Trondheim, Norway.
Jørgen G BramnessNorwegian National Advisory Unit on Concurrent Substance Abuse and Mental Health Disorders, Innlandet Hospital Trust, Hamar, Norway.
Olav SpigsetDepartment of Clinical Pharmacology, St. Olav University Hospital, Trondheim, Norway.
Norwegian University of Science and Technology · NOHaukeland University Hospital · NOInnlandet Hospital Trust · NOSt Olav's University Hospital · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

rationaleAlthough methadone maintenance treatment (MMT) has long been used for opioid addiction, our knowledge on its pharmacokinetics is still limited.

objectivesWe aimed to investigate effects of age, gender, and various co-medications on methadone serum concentration-to-dose ratio (CDR) in a naturalistic setting.

methodsIn total, 4425 routine serum methadone concentrations obtained from 1691 MMT patients in the period October 1999 to July 2017 were included. Information about doses, age, gender, and concurrent medications was available in the laboratory database at the Department of Clinical Pharmacology at St. Olav University Hospital in Trondheim, Norway. A log-linear mixed model was used when analyzing the data.

resultsMean age was 38.4 (range, 21-78) years and 70% were men. Mean CDR was 332 (range, 7-1776) (ng/mL)/(100 mg/d). Concomitant medication with at least one out of totally 170 drugs was recorded in 26% of the samples. CDRs were significantly lower in women (- 9%; confidence interval (CI), - 13%, - 4%; p = 0.001) and with concurrent use of CYP inducers (- 36%; CI, - 44%, - 28%; p < 0.001), but higher using CYP3A4 inhibitors as co-medications (+ 36%; CI, + 10%, + 68%; p = 0.005).

conclusionsOur results warrant taking into consideration gender differences in methadone metabolism as well as the impact of potential drug-drug interactions to obtain an optimal therapeutic effect and avoid adverse effects in MMT. Although the clinical implications of the altered drug levels require further study, our results call for close clinical monitoring of all patients undergoing MMT, preferably along with laboratory measurements of methadone serum concentrations.

Indexed as

Analgesics, OpioidMethadoneOpioid-Related DisordersAdultAgedDrug InteractionsFemaleHumansMaleMiddle AgedNorwayOpiate Substitution TreatmentSex FactorsYoung AdultAnalgesics, OpioidMethadoneCytochrome P-450 enzyme systemDrug interactionsDrug monitoringGenderMethadonePharmacokinetics

Identifiers

PMID31139877
OpenAlexW2947552786

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.